Legato Capital Management LLC Mirum Pharmaceuticals, Inc. Transaction History
Legato Capital Management LLC
- $703 Million
- Q1 2025
A detailed history of Legato Capital Management LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Legato Capital Management LLC holds 16,552 shares of MIRM stock, worth $733,419. This represents 0.11% of its overall portfolio holdings.
Number of Shares
16,552
Previous 13,395
23.57%
Holding current value
$733,419
Previous $553,000
34.72%
% of portfolio
0.11%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding MIRM
# of Institutions
224Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$301 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$211 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$143 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$124 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$113 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.63B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...